HOME >> BIOLOGY >> NEWS
Unique international conference to focus on effectiveness, safety of medicinal herbs

By David Williamson
UNC-CH News Services

CHAPEL HILL -- Are medicinal herbs -- now extremely popular in the United States and abroad but only poorly regulated -- safe? Do they really work? How much should a person take in hope of producing the desired effect? Those are the chief questions top researchers will try to answer March 2-3 as the University of North Carolina at Chapel Hill hosts the first international scientific conference on "The Efficacy and Safety of Medicinal Herbs."

Speakers from Canada, England, Germany and the United States will discuss what's been confirmed about eight of the world's most widely used herbs at the university's Friday Center, according to conference co-chair Dr. Lenore Arab. Those herbs are garlic, ginseng, ginko biloba, comfrey, saw palmetto, feverfew, echinacea and St. John's wort.

"It's essential that health professionals know what we know about these products and what's still speculation so that they can give informed advice," said Arab, professor of epidemiology and nutrition at the UNC-CH schools of medicine and public health. "Right now, the public has stopped asking, and even if they were, most health professionals do not feel that they are in a position to give advice.

"As a result, the train is running wild down the track. People are self-medicating without any guidance. They might be taking extremely high, possibly dangerous, doses because they think more is better, or they may be getting so little that they're simply wasting their money."

As an example, she cited comfrey, which can cause liver damage and even liver failure. Banned in Canada and Europe, the herb is still widely available in U.S. health food stores.

Some 400 scientists, nutritionists and others are expected to attend the conference, Arab said.

Dr. Varro Tyler, professor and dean emeritus of pharmacy at Purdue University, will give the keynote address, "Herbal Medicine: From the
'"/>

Contact: David Williamson
David_Williamson@unc.edu
919-962-8596
University of North Carolina at Chapel Hill
13-Jan-2000


Page: 1 2

Related biology news :

1. Unique partnership between UH, FDA opens path for scientific exchange
2. Unique two-part macroemulsion offers new approach to cleaning up contaminated aquifers
3. Unique fleet of underwater vehicles to gather elusive environmental data
4. Unique feeding behavior discovered for snakes
5. Unique population of muscle stem cells found in mice
6. Unique social system found in famous Tsavo lions
7. Unique national park for orchids to be declared in Africa
8. Unique genetic alteration in presenilin 1 gene predisposes some Caribbean Hispanics to early-onset Alzheimers disease
9. Unique UNC study confirms suspected worldwide epidemic of childhood obesity
10. Scientists find just how discriminating a worm can be: Unique system of overlapping odor sensors discovered
11. Unique study reveals new details on how genes are transcribed

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2017)... Inc. (NASDAQ: AWRE ), a leading supplier of ... quarter and year ended December 31, 2016. ... compared to $6.9 million in the same quarter last year. ... million compared to $2.6 million in the fourth quarter of ... $0.5 million, or $0.02 per diluted share, which compares to ...
(Date:2/7/2017)... 7, 2017   MedNet Solutions , an innovative ... of clinical research, is pleased to announce that the ... innovative, highly flexible and award winning eClinical solution, is ... iMedNet is a proven Software-as-a-Service (SaaS) clinical research ... (EDC), but also delivers an entire suite of eClinical ...
(Date:2/3/2017)... 3, 2017  Texas Biomedical Research Institute announced that its ... Schlesinger as the Institute,s new President and CEO. Dr. ... 31, 2017. He is currently the Chair of the Department ... for Microbial Interface Biology at Ohio State University. ... President and CEO of Texas Biomed," said Dr. James ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... Financial ... data, unaudited)Three Months Ended December 31,Twelve Months Ended December ... $           300$ ... Net Product Revenue 3539(10)%9498(4)%Kuvan Net ... Revenue  756025%297303(2)%Vimizim Net Product Revenue ...
(Date:2/23/2017)... 2017  MIODx announced today that it has ... technologies from the University of California, San Francisco ... monitor a patient for response to immune checkpoint ... second license extends the technology with a method ... have an immune-related adverse event (IRAE) from their ...
(Date:2/23/2017)... ROCHESTER, Minn. , Feb. 23, 2017 /PRNewswire/ ... a new product line of oncolytic vaccinia viruses ... Genelux Corporation as part of Genelux,s proprietary, vaccinia ... "We are excited to enter into a partnership ... time, selected oncolytic vaccinia viruses for use in ...
(Date:2/23/2017)... ... 23, 2017 , ... David Nolte, PhD accepted Purdue University’s ... Purdue Research Park of West Lafayette, Indiana. , The top commercialization award ... and success with, commercializing discoveries from Purdue research. “This award is truly an ...
Breaking Biology Technology:
Cached News: